Franc Sylvia, Charpentier Guillaume
Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, Centre d'Etude et de Recherche pour l'Intensification du Traitement du Diabète (CERITD) Evry, and LBEPS, Univ Evry, IRBA, Université Paris Saclay, Evry, France.
Diabetes Obes Metab. 2025 Sep;27(9):4662-4673. doi: 10.1111/dom.16540. Epub 2025 Jun 25.
Persistent poor glycaemic control is frequently observed in subjects with type 1 diabetes (T1D). The burden of diabetes self-management, fear of hypoglycaemia, and other diabetes-specific stressors are associated with diabetes distress and poor glycaemic control. However, psychological interventions to reduce diabetes distress have only benefited certain groups of patients. Psychosocial stressors (unemployment, financial problems) can lead to psychosocial distress and persistent poor glycaemic control in subjects with T1D. Therefore, diabetes distress and psychosocial distress can cause a similar state of 'emotional distress'. Here we conducted a systematic review of emotional distress and persistent poor glycaemic control in subjects with T1D. A total of 108 articles were identified in bibliographic databases (PubMed, Google Scholar, ScienceDirect, PsycNet APA, ERIC, EMBASE and Cochrane) and other literature sources. Of these, 24 articles were included in the analysis. As expected, diabetes stressors have been found to combine with psychosocial stressors to produce emotional distress and worsen glycaemic control. Psychological resilience and positive life events reduced the impact of emotional distress on glycaemic control. The EMBARK trial demonstrated the efficacy of an emotion-focused approach in achieving clinically significant long-term improvement in glycaemic control. In conclusion, emotional distress could be a new therapeutic target against persistent poor glycaemic control. This hypothesis could be tested in intervention trials including: (i) diabetes distress and psychosocial distress as main outcome measures, (ii) positive life events as a secondary outcome measure, and (iii) psychological resilience among the baseline characteristics of study participants.
1型糖尿病(T1D)患者中经常观察到血糖控制持续不佳。糖尿病自我管理的负担、对低血糖的恐惧以及其他特定于糖尿病的压力源与糖尿病困扰和血糖控制不佳有关。然而,减轻糖尿病困扰的心理干预仅使某些患者群体受益。社会心理压力源(失业、经济问题)可导致T1D患者出现社会心理困扰和血糖控制持续不佳。因此,糖尿病困扰和社会心理困扰可导致类似的“情绪困扰”状态。在此,我们对T1D患者的情绪困扰和血糖控制持续不佳进行了系统综述。在书目数据库(PubMed、谷歌学术、ScienceDirect、PsycNet APA、ERIC、EMBASE和Cochrane)及其他文献来源中,共识别出108篇文章。其中,24篇文章纳入分析。正如预期的那样,已发现糖尿病压力源与社会心理压力源相结合会产生情绪困扰并使血糖控制恶化。心理复原力和积极的生活事件减少了情绪困扰对血糖控制的影响。EMBARK试验证明了以情绪为中心的方法在实现血糖控制临床上显著的长期改善方面的疗效。总之,情绪困扰可能是针对血糖控制持续不佳的一个新的治疗靶点。这一假设可在干预试验中进行检验,包括:(i)以糖尿病困扰和社会心理困扰作为主要结局指标,(ii)以积极生活事件作为次要结局指标,以及(iii)将心理复原力纳入研究参与者的基线特征中。